Fonted Biomedical Technology

Fonted Biomedical is a clinical-stage biotechnology company focused on the discovery and development of next-generation immunotherapies for cancer and autoimmune diseases. The company leverages its proprietary platform to identify and target novel immune checkpoints, aiming to overcome resistance to current standard-of-care treatments. Its lead programs include innovative antibodies targeting TIGIT and other emerging pathways, currently undergoing evaluation in early-phase clinical trials. Based in Suzhou, China, Fonted Biomedical integrates deep biological insights with efficient drug development capabilities to address significant unmet medical needs in oncology.